| Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose C Lawhn-Heath, TA Hope, J Martinez, EK Fung, J Shin, Y Seo, RR Flavell The lancet oncology 23 (2), e75-e87, 2022 | 37 | 2022 |
| 68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study J Martinez, K Subramanian, D Margolis, E O'Dwyer, J Osborne, ... Translational Oncology 15 (1), 101242, 2022 | 14 | 2022 |
| Decision-making support among racial and ethnic minorities diagnosed with breast or prostate cancer: A systematic review of the literature AP DeRosa, Y Grell, D Razon, A Komsany, LC Pinheiro, J Martinez, ... Patient Education and Counseling 105 (5), 1057-1065, 2022 | 13 | 2022 |
| Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in … K Subramanian, J Martinez, S Huicochea Castellanos, J Ivanidze, ... Scientific Reports 13 (1), 8321, 2023 | 4 | 2023 |
| Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial J Martinez, K Subramanian, SH Castellanos, C Thomas, AR Choudhury, ... Translational Oncology 28, 101593, 2023 | 4 | 2023 |
| Phase I/II study of 225Ac-J591 plus 177Lu-PSMA-I&T for progressive metastatic castration-resistant prostate cancer. JT Nauseef, J Osborne, P Gregos, C Thomas, M Bissassar, S Singh, ... Journal of Clinical Oncology 40 (16_suppl), TPS5100-TPS5100, 2022 | 4 | 2022 |
| Access to cardiac PET/CT by sarcoidosis patients and cost-effectiveness analysis of cardiac PET/MR compared to the standard of care K Subramanian, J Martinez, JR Osborne, S Nicholson, J Van Parys, ... Clinical imaging 94, 50-55, 2023 | 3 | 2023 |
| Abstract CT143: Results of combined targeting of prostate-specific membrane antigen (PSMA) with alpha-radiolabeled antibody 225Ac-J591 and beta-radiolabeled ligand 177Lu-PSMA I … ST Tagawa, E Fung, MO Niaz, M Bissassar, S Singh, A Patel, A Tan, ... Cancer Research 82 (12_Supplement), CT143-CT143, 2022 | 1 | 2022 |
| Self-reported race and zip code by men with prostate cancer in New York City and association with access to PSMA PET scans. JT Nauseef, J Martinez Zuloaga, K Subramanian, P Gregos, M Bissassar, ... Journal of Clinical Oncology 40 (16_suppl), e17007-e17007, 2022 | | 2022 |
| MP51-17 DEMOGRAPHICS AND SOCIOECONOMIC DESCRIPTION OF PATIENTS WITH PROSTATE CANCER IN WHOM A PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET WAS PERFORMED: A SINGLE-INSTITUTION … J Martinez, K Subramanian, M Niaz, T Getz, A Patel, J Osborne, S Tagawa The Journal of Urology 207 (Supplement 5), e883, 2022 | | 2022 |
| Assessment of patient-reported outcomes (PROs) and longer-term adverse events (AEs) in phase I study of 225Ac-J591-PSMA for metastatic castration-resistant … JT Nauseef, C Thomas, B Ho, J Martinez Zuloaga, BD Gonzalez, M Sun, ... Journal of Clinical Oncology 40 (6_suppl), 77-77, 2022 | | 2022 |
| Quantitative assessment of PSMA imaging before and after 177Lu-PSMA-617 treatment in a Ph I/II trial. JT Nauseef, C Thomas, M Sun, AO Sartor, S Singh, M Bissassar, ... Journal of Clinical Oncology 40 (6_suppl), 37-37, 2022 | | 2022 |
| Molecular Imaging J Fox, J., Huicochea Castellanos, S., Martinez AAOS Resident Orthopaedic Core Knowledge (ROCK) [online course] 2021, NA, 2021 | | 2021 |
| Dual X-Ray Absorptiometry: what the radiologist needs to know. S Imad, D., Martinez, J., Subramanian, K., Ivanidze, J., Osborne, J ... RSNA 2021, 2021 | | 2021 |
| The Light From The Unknown - PSMA PET/MR Staging For Prostate Cancer S Martinez, J., Subramanian, K., Imad, D., Pereira, R., Margolis, D ... RSNA 2021, 2021 | | 2021 |
| 68Ga PSMA PET is a better imaging modality than multiparametric MR in biochemical recurrent disease. S Martinez, J., Subramanian, K., Imad, D., Margolis, D., Osborne, J ... RSNA 2021, 2021 | | 2021 |
Kritika SubramanianMontefiore Medical CenterVerified email at montefiore.org
